Wells Fargo analyst Mohit Bansal upgraded Amgen to Overweight from Equal Weight with a price target of $265, down from $275.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AMGN:
- Cantor biopharma/biotech analysts to hold analyst/industry conference call
- AMGEN ANNOUNCES 2023 SECOND QUARTER DIVIDEND
- Amgen to present new Repatha combined data from Phase 3 FOURIER trials
- Horizon Therapeutics reports Q4 EPS $1.21, consensus $1.09
- Early notable gainers among liquid option names on February 17th